Lack of clinical trial participation may contribute to lower surv...( A new study finds poor survival rates a...),Health

A new study finds poor survival rates among young adults and older adolescents with some cancers may be partially explained by the lack of participation in clinical trials. The study, published in the May 1, 2005 issue of CANCER (http://www.interscience.wiley.com/cancer-newsroom), a peer-reviewed journal of the American Cancer Society, found that age-dependent survival rates among patients with sarcomas - except Kaposi Sarcoma (KS) - correlated with clinical trial participation rates.

While survival rates among all ages overall as well as among younger and older patients have shown vast improvements over the past 25 years, the same has not been shown for patients between 15-45 years, among whom survival has improved little over the same time period. Explanations for the finding have included differences in physical tolerances to therapy, tumor biology, treatment options, health insurance coverage, and availability of new treatments and protocols.

Previous studies investigating individual cancer types, such as leukemia, have also shown that age-dependent survival may be linked to rates of participation in and availability of clinical trials. The 15-45 year age group is one of the least studied and also the least likely to be treated at a large health care institution that offers clinical trials. Participation in cancer clinical trials has been shown to improve survival. Young adults with Kaposi Sarcoma have shown significant survival and mortality benefits after improvements in clinical trial participation.

Archie Bleyer, M.D. of the M. D. Anderson Cancer Center in Houston and colleagues investigated whether KS and non-KS sarcoma survival and mortality rates were related to participation in clinical trials.

The researchers found participation in a clinical trial correlated with survival improvement in both KS and non-KS sarcomas. For soft-tissue and bone sarcomas, patient
'"/>

Contact: David Greenberg
dgreenbe@wiley.com
201-748-6484
John Wiley & Sons, Inc.
28-Mar-2005

Page: 1 2
Related medicine news :

1. British hospitals need clinical ethicists
2. Obtaining patient consent for clinical audit is unworkable without extra resources
3. Sharing clinical trial results with participants may be beneficial
4. Two years after gene therapy treatments, severe angina patients showed prolonged clinical benefit
5. PENN begins clinical trial of newest technology to treat thoracic aortic aneurysms
6. Most episodes of HIV blips not clinically significant in patients receiving HAART
7. NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks
8. New non-hormonal hot flash treatment set for clinical trial
9. Study naming hospitals in top 5% for clinical quality released by HealthGrades
10. Future of clinical medicine research is at risk, warns professor
11. Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers